Cited by 783Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Open access

Haidet-Phillips, Amanda M, Hester, Mark E, Miranda, Carlos J, Meyer, Kathrin, Braun, Lyndsey, Frakes, Ashley, Song, SungWon, Likhite, Shibi, Murtha, Matthew J, Foust, Kevin D, Rao, Meghan, Eagle, Amy, Kammesheidt, Anja, Christensen, Ashley, Mendell, Jerry R, Burghes, Arthur H M, Kaspar, Brian K·2011·Nature Biotechnology

DOI 10.1038/nbt.1957PMC PMC3170425

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS. However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases. Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.1957

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Directed differentiation of embryonic stem cells into motor neurons.
Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00835-8 · Cited by 1,792
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“Recently, novel vectors have been shown to efficiently target astrocytes of adult brain and spinal cor”
BackgroundSelf-citation
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,131

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 101–200 of 783

Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes
Humphrey, J., Venkatesh, S., Hasan, R., Herb, J. T., de Paiva Lopes, K., Küçükali, F., Byrska-Bishop, M., Evani, U. S., Narzisi, G., Fagegaltier, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01205-3 · Cited by 138
Delayed Disease Onset and Extended Survival in the SOD1G93ARat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
Thomsen, G. M., Gowing, G., Latter, J., Chen, M., Vit, J., Staggenborg, K., Avalos, P., Alkaslasi, M. R., Ferraiuolo, L., Likhite, S. B., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2037-14.2014 · Cited by 137
Self-citation
Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis
Almad, A. A., Doreswamy, A., Gross, S. K., Richard, J., Huo, Y., Haughey, N. J., & Maragakis, N. J. (2016) · Glia · doi:10.1002/glia.22989 · Cited by 146
The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion
Miyamoto, N., Magami, S., Inaba, T., Ueno, Y., Hira, K., Kijima, C., Nakajima, S., Yamashiro, K., Urabe, T., & Hattori, N. (2020) · Glia · doi:10.1002/glia.23814 · Cited by 138
Semaphorins in Adult Nervous System Plasticity and Disease
Carulli, D., de Winter, F., & Verhaagen, J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.672891 · Cited by 137
A large animal model of spinal muscular atrophy and correction of phenotype
Duqué, S. I., Arnold, W. D., Odermatt, P., Li, X., Porensky, P. N., Schmelzer, L., Meyer, K., Kolb, S. J., Schümperli, D., Kaspar, B. K., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24332 · Cited by 148
Self-citation
SOD1 as a Molecular Switch for Initiating the Homeostatic ER Stress Response under Zinc Deficiency
Homma, K., Fujisawa, T., Tsuburaya, N., Yamaguchi, N., Kadowaki, H., Takeda, K., Nishitoh, H., Matsuzawa, A., Naguro, I., & Ichijo, H. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.038 · Cited by 137
Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis
Wang, L., Popko, B., Tixier, E. N., & Roos, R. P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.010 · Cited by 136
Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms
Madill, M., McDonagh, K., Ma, J., Vajda, A., McLoughlin, P., O’Brien, T., Hardiman, O., & Shen, S. (2017) · Molecular Brain · doi:10.1186/s13041-017-0300-4 · Cited by 134
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis
Dodge, J. C., Treleaven, C. M., Pacheco, J., Cooper, S., Bao, C., Abraham, M., Cromwell, M. A., Sardi, S. P., Chuang, W., Sidman, R. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508767112 · Cited by 134
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
Peviani, M., Salvaneschi, E., Bontempi, L., Petese, A., Manzo, A., Rossi, D., Salmona, M., Collina, S., Bigini, P., & Curti, D. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.010 · Cited by 136
Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
Kanouchi, T., Ohkubo, T., & Yokota, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301826 · Cited by 130
Astrocyte Depletion Impairs Redox Homeostasis and Triggers Neuronal Loss in the Adult CNS
Schreiner, B., Romanelli, E., Liberski, P. P., Ingold‐Heppner, B., Sobottka, B., Hartwig, T., Chandrasekar, V., Johannssen, H. C., Zeilhofer, H. U., Aguzzi, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.051 · Cited by 129
Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis
Obrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2020) · Antioxidants · doi:10.3390/antiox9090901 · Cited by 132
TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications
Luo, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051206 · Cited by 135
Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis
Harten, A. C. M. V., Phatnani, H. P., & Przedborski, S. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.04.008 · Cited by 123
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis
Dodge, J. C., Treleaven, C. M., Fidler, J. A., Tamsett, T. J., Bao, C., Searles, M., Taksir, T. V., Misra, K., Sidman, R. L., Cheng, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308421110 · Cited by 124
Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-β1
Tripathi, P., Rodriguez-Muela, N., Klim, J. R., de Boer, A. S., Agrawal, S., Sandoe, J., Lopes, C. S., Ogliari, K. S., Williams, L. A., Shear, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.008 · Cited by 123
Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo
Qian, K. X., Huang, H., Peterson, A., Hu, B., Maragakis, N. J., Ming, G., Chen, H., & Zhang, S. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.003 · Cited by 128
Mutant C9orf72 human iPSC‐derived astrocytes cause non‐cell autonomous motor neuron pathophysiology
Zhao, C. N., Devlin, A., Chouhan, A. K., Selvaraj, B. T., Stavrou, M., Burr, K., Brivio, V., He, X., Mehta, A. R., Story, D., et al. (2019) · Glia · doi:10.1002/glia.23761 · Cited by 129
C/EBPβ and C/EBPδ transcription factors: Basic biology and roles in the CNS
Pulido-Salgado, M., Vidal-Taboada, J. M., & Saura, J. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.06.003 · Cited by 121
Contribution of astrocytes to neuropathology of neurodegenerative diseases
Acıoğlu, Ç., Li, L., & Elkabes, S. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147291 · Cited by 119
Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk
Passaro, A. P., Lebos, A. L., Yao, Y., & Stice, S. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676621 · Cited by 124
Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.03.019 · Cited by 114
Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 125
Macrophage Migration Inhibitory Factor as a Chaperone Inhibiting Accumulation of Misfolded SOD1
Israelson, A., Ditsworth, D., Sun, S., Song, S., Liang, J., Hruška-Plocháň, M., McAlonis‐Downes, M., Abu‐Hamad, S., Zoltsman, G., Shani, T., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.034 · Cited by 114
Self-citation
Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS
Drechsel, D. A., Estévez, Á. G., Barbeito, L., & Beckman, J. S. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9322-y · Cited by 117
MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
Peruzzi, P., Bronisz, A., Nowicki, M. O., Wang, Y., Ogawa, D., Price, R., Nakano, I., Kwon, C.-H., Hayes, J., Lawler, S. E., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not055 · Cited by 97
Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress
Rojas, F., Cortés, N., Abarzúa, S., Dyrda, A., & van Zundert, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00024 · Cited by 120
SIRT3 and mitochondrial metabolism in neurodegenerative diseases
Salvatori, I., Valle, C., Ferri, A., & Carrì, M. T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.04.012 · Cited by 110
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
Winer, L. K., Srinivasan, D., Chun, S. J., Lacomis, D., Jaffa, M., Fagan, A. M., Holtzman, D. M., Wancewicz, E. V., Bennett, C. F., Bowser, R. P., et al. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.593 · Cited by 113
Translational potential of astrocytes in brain disorders
Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 115
Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia
Xia, Q., Hu, Q., Wang, H., Yang, H., Gao, F., Ren, H., Chen, D., Fu, C., Zheng, L. P., Zhen, X., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.69 · Cited by 117
Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
Patel, P., Križ, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., & Julien, J. (2014) · Molecular Therapy · doi:10.1038/mt.2013.239 · Cited by 114
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
Abati, E., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738390 · Cited by 107
Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability
Fritz, E., Izaurieta, P., Weiss, A., Mir, F. R., Rojas, P., González, D., Rojas, F., Brown, R. H., Madrid, R., & van Zundert, B. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00500.2012 · Cited by 116
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord
Sareen, D., Gowing, G., Sahabian, A., Staggenborg, K., Paradis, R., Avalos, P., Latter, J., Ornelas, L., Garcia, L., & Svendsen, C. N. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23578 · Cited by 110
SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status
Sheng, Y., Chattopadhyay, M., Whitelegge, J. P., & Valentine, J. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611212220010 · Cited by 115
Misfolded SOD1 is not a primary component of sporadic ALS
Cruz, S. D., Bui, A., Saberi, S., Lee, S. K., Stauffer, J. E., McAlonis‐Downes, M., Schulte, D. J., Pizzo, D. P., Parone, P. A., Cleveland, D. W., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1688-8 · Cited by 113
Adeno‐associated virus–delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model
Stoica, L., Todeasa, S. H., Cabrera, G. T., Salameh, J. S., ElMallah, M. K., Mueller, C., Brown, R. H., & Sena‐Esteves, M. (2016) · Annals of Neurology · doi:10.1002/ana.24618 · Cited by 107
Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling
Harding, O. J., Holzer, E., Riley, J. F., Martens, S., & Holzbaur, E. L. F. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.08.005 · Cited by 105
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
Allen, S. P., Hall, B., Castelli, L. M., Francis, L. I., Woof, R., Siskos, A., Kouloura, E., Gray, E., Thompson, A. G., Talbot, K., et al. (2019) · Brain · doi:10.1093/brain/awy353 · Cited by 102
The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS
Obrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126352 · Cited by 104
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 116
The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia
Radford, R. A. W., Morsch, M., Rayner, S. L., Cole, N. J., Pountney, D. L., & Chung, R. S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00414 · Cited by 105
Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?
Lee, S., & Kim, H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.1.1 · Cited by 101
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Barák, M., Fedorová, V., Pospíšilová, V., Raška, J., Vochyánová, S., Sedmík, J., Hříbková, H., Klímová, H., Váňová, T., & Bohačiaková, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10254-3 · Cited by 102
Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation
Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 100
Pathophysiological insights into ALS with C9ORF72 expansions
Williams, K. L., Fifita, J. A., Vucic, S., Durnall, J. C., Kiernan, M. C., Blair, I. P., & Nicholson, G. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304529 · Cited by 104
An enhanced integrated stress response ameliorates mutant SOD1-induced ALS
Wang, L., Popko, B., & Roos, R. P. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt658 · Cited by 101
Astrocytes expressing ALS‐linked mutant FUS induce motor neuron death through release of tumor necrosis factor‐alpha
Kia, A., McAvoy, K. J., Krishnamurthy, K., Trotti, D., & Pasinelli, P. (2018) · Glia · doi:10.1002/glia.23298 · Cited by 100
Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers
Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 100
Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders
Afridi, R., Kim, J., Rahman, M. H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00020 · Cited by 102
Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis–causing mutations
Doss, S. V., Kemp, Z., Hatzipetros, T., Vieira, F. G., & Valdez, G. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23848 · Cited by 101
Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes
Forsberg, K., Graffmo, K. S., Pakkenberg, B., Weber, M., Nielsen, M., Marklund, S. L., Brännström, T., & Andersen, P. M. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319386 · Cited by 99
Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling
Rojas, F., González, D., Cortés, N., Ampuero, E., Hernández, D. E., Fritz, E., Abarzúa, S., Martinez, A. N., Elorza, Á. A., Alvarez, A. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00203 · Cited by 97
SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells
Peggion, C., Scalcon, V., Massimino, M. L., Nies, K., Lopreiato, R., Rigobello, M. P., & Bertoli, A. (2022) · Antioxidants · doi:10.3390/antiox11040614 · Cited by 106
Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 95
Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1)
Harlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94
Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis
Thomsen, G. M., Avalos, P., Ma, A. A., Alkaslasi, M. R., Cho, N., Wyss, L. S., Vit, J., Godoy, M. I., Suezaki, P., Shelest, O., et al. (2018) · Stem Cells · doi:10.1002/stem.2825 · Cited by 97
Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model
Sunyach, C., Michaud, M., Arnoux, T., Bernard‐Marissal, N., Aebischer, J., Gourdou‐Latyszenok, V., Gouarné, C., Raoul, C., Pruss, R. M., Bordet, T., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.013 · Cited by 94
Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research
Su, X., Broach, J. R., Connor, J. R., Gerhard, G. S., & Simmons, Z. (2014) · Muscle & Nerve · doi:10.1002/mus.24198 · Cited by 94
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 93
Targeted gene silencing in the nervous system with CRISPR-Cas13
Powell, J. E., Lim, C. K. W., Krishnan, R. S. G., McCallister, T. X., Saporito-Magriñá, C., C., M. A. Z., McPheron, G. D., & Gaj, T. (2022) · Science Advances · doi:10.1126/sciadv.abk2485 · Cited by 96
Abnormal Intracellular Calcium Signaling and SNARE-Dependent Exocytosis Contributes to SOD1G93A Astrocyte-Mediated Toxicity in Amyotrophic Lateral Sclerosis
Kawamata, H., Ng, S. K., Diaz, N., Burstein, S., Morel, L., Osgood, A., Sider, B., Higashimori, H., Haydon, P. G., Manfredi, G., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2689-13.2014 · Cited by 97
Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive statesPreprint
Ziff, O. J., Clarke, B. E., Taha, D. M., Crerar, H., Luscombe, N. M., & Patani, R. (2021) · Genome Research · doi:10.1101/gr.275939.121 · Cited by 91
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Neuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 95
Glia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
Amyotrophic lateral sclerosis: update and new developments
Perry, J. J. P., Pratt, A. J., & Getzoff (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19803 · Cited by 94
Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
Geevasinga, N., Menon, P., Nicholson, G. A., Ng, K., Howells, J., Kril, J. J., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1872 · Cited by 88
The BH4 domain of Bcl-XL rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals
Martorana, F., Brambilla, L., Valori, C. F., Bergamaschi, C., Roncoroni, C., Aronica, E., Volterra, A., Bezzi, P., & Rossi, D. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr513 · Cited by 94
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
Martier, R., Liefhebber, J. M. P., García‐Osta, A., Miniarikova, J., Cuadrado‐Tejedor, M., Espelosin, M., Ursúa, S., Petry, H., van Deventer, S. J. H., Evers, M. M., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.001 · Cited by 91
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson’s disease
Jacquet, A. D. R., Tancredi, J. L., Lemire, A. L., DeSantis, M. C., Li, W., & O’Shea, E. K. (2021) · eLife · doi:10.7554/elife.73062 · Cited by 91
Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis
Ngo, S. T., Steyn, F. J., Huang, L., Mantovani, S., Pfluger, C. M., Woodruff, T. M., O’Sullivan, J. D., Henderson, R. D., & McCombe, P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.053 · Cited by 90
Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons
Arredondo, C., Cefaliello, C., Dyrda, A., Jury, N., Martínez, P., Díaz, I. D. P., Amaro, A., Tran, H., Morales, D., Pertusa, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.02.010 · Cited by 89
Glial Glutamine Homeostasis in Health and Disease
Andersen, J. V., & Schousboe, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03771-1 · Cited by 92
Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 90
Neuroinflammation in motor neuron disease.
Komine, O., & Yamanaka, K. (2015) · Europe PMC (PubMed Central) · doi:10.18999/nagjms.77.4.537 · Cited by 87
The multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 88
A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model
Biferi, M. G., Cohen-Tannoudji, M., Cappelletto, A., Giroux, B., Roda, M., Astord, S., Marais, T., Bos, C., Voït, T., Ferry, A., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.017 · Cited by 90
On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases
Secondo, A., Bagetta, G., & Amantea, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00087 · Cited by 90
Distinct repertoires of microRNAs present in mouse astrocytes compared to astrocyte-secreted exosomes
Jovičić, A., & Gitler, A. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171418 · Cited by 86
Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS
Trias, E., Beilby, P. R., Kovacs, M., Ibarburu, S., Varela, V., Barreto-Núñez, R., Bradford, S. C., Beckman, J. S., & Barbeito, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00042 · Cited by 85
Should We Stop Saying ‘Glia’ and ‘Neuroinflammation’?
Masgrau, R., Guaza, C., Ransohoff, R. M., & Galea, E. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.005 · Cited by 88
The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
Wobst, H. J., Mack, K. L., Brown, D. G., Brandon, N. J., & Shorter, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21661 · Cited by 90
Recent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair
Hart, C. G., & Karimi‐Abdolrezaee, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24922 · Cited by 88
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
Abati, E., Manini, A., Comi, G. P., & Corti, S. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04408-w · Cited by 85
DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity
Kok, J. R., Palminha, N. M., Souza, C. D. S., El‐Khamisy, S. F., & Ferraiuolo, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03872-0 · Cited by 89
The multi‐functional RNA‐binding protein G3BP1 and its potential implication in neurodegenerative disease
Sidibé, H., Dubinski, A. F., & Velde, C. V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15280 · Cited by 88
Early pathogenesis in the adult‐onset neurodegenerative disease amyotrophic lateral sclerosis
van Zundert, B., Izaurieta, P., Fritz, E., & Álvarez, F. J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24234 · Cited by 84
αVβ3 Integrin regulates astrocyte reactivity
Lagos‐Cabré, R., Álvarez, Á., Kong, M., Burgos‐Bravo, F., Cárdenas, A., Rojas-Mancilla, E., Pérez-Núñez, R., Herrera‐Molina, R., Rojas, F., Schneider, P., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0968-5 · Cited by 81
Cortical neurotoxic astrocytes with early ALS pathology and miR-146a deficit replicate gliosis markers of symptomatic SOD1G93A mouse model
Gomes, C., Cunha, C., Nascimento, F., Ribeiro, J. A., Vaz, A. R., & Brites, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1220-8 · Cited by 79
Silencing strategies for therapy of SOD1-mediated ALS
van Zundert, B., & Brown, R. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.059 · Cited by 81
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
Tokuda, E., Takei, Y.-I., Ohara, S., Fujiwara, N., Hozumi, I., & Furukawa, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0341-5 · Cited by 81
Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update
Pansarasa, O., Rossi, D., Berardinelli, A. L., & Cereda, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8578-4 · Cited by 79
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
Starr, A., & Sattler, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.011 · Cited by 78
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622095802 · Cited by 84
Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS
Das, M. M., & Svendsen, C. N. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.020 · Cited by 76

Authors: Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J. R., Burghes, A. H. M., & Kaspar, B. K.
Affiliations: Nationwide Children's Hospital (US)
Ambry Genetics (United States) (US)
The Ohio State University (US)
Corresponding author: Kaspar, Brian K
ORCID: Hester, Mark E
Miranda, Carlos J
Meyer, Kathrin
Likhite, Shibi
Foust, Kevin D
Mendell, Jerry R
Burghes, Arthur H M
Kaspar, Brian K
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2011-08-10
Volume: 29
Issue: 9
Pages: 824-828
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.1957
PMC: PMC3170425
OpenAlex: W2059355164
Cited by: 782
References: 30
Citations by year: 2026: 21 · 2025: 29 · 2024: 43 · 2023: 38 · 2022: 54 · 2021: 46 · 2020: 68 · 2019: 59 · 2018: 55 · 2017: 58 · 2016: 66 · 2015: 59 · 2014: 70 · 2013: 59 · 2012: 50
FWCI: 37.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (RC2NS069476, R01 NS644912-1A1, RC2 NS69476-01, R01NS064492, T32NS077984, F31NS058224)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: amyotrophic lateral sclerosis, astrocytes, motor neuron toxicity, sporadic ALS, familial ALS, SOD1, disease mechanisms
MeSH terms: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Cell Differentiation, Cell Line, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Motor Neurons, Mutation, Superoxide Dismutase, Signal Transduction, Biomarkers, Sequence Analysis, DNA, Coculture Techniques, Mice, Embryonic Stem Cells, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks